Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344).

Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst. 2006 Sep 20; 98(18):1335-8.

View in: PubMed

subject areas

Aged
Algorithms
Area Under Curve
Breast Neoplasms
Disease-Free Survival
Female
Humans
Lymphatic Metastasis
Medicaid
Medicare
Middle Aged
Multicenter Studies as Topic
Neoplasm Recurrence, Local
ROC Curve
Sensitivity and Specificity
United States

authors with profiles

Richard Schilsky